Friday, March 22, 2013

SAC: Inside a Star Hedge Fund: Lots of Big Bets, Built Fast

From WSJ: SAC Capital Advisors LP bet big on a firm called Ardea Biosciences Inc. at the beginning of last year.

Diving into a small stock it never before reported owning, the hedge-fund firm bought 1.2 million shares, which at the end of the first quarter were valued at $26.7 million.  Three weeks later, a stake of that size was worth $12.1 million more. On April 23, Britain's AstraZenec said it would buy Ardea, the culmination of two months of confidential negotiations. The deal sent the stock soaring 52% that day.

Such high-stakes trading over the years has made SAC the subject of admiration and envy on Wall Street….

No comments:

Post a Comment